杭州鸿泉物联网技术股份有限公司 第四条 公司董事会成员中应当至少包括三分之一独立董事，且其中至少包 括一名会计专业人士。 公司董事会下设薪酬与考核委员会、审计委员会、提名委员会、战略发展委 员会，独立董事应当在薪酬与考核委员会、审计委员会、提名委员会中占多数， 并担任召集人。审计委员会成员应当为不在上市公司担任高级管理人员的董事， 其中独立董事应当过半数，并由独立董事中会计专业人士担任召集人。 第二章 独立董事的独立性要求 独立董事工作制度 （2025 年 12 月） 第一章 总 则 第一条 为进一步完善杭州鸿泉物联网技术股份有限公司(以下简称公司)法 人治理结构，促进公司的规范运作，维护公司整体利益，保障全体股东特别是中 小股东的合法权益不受侵害，根据《中华人民共和国公司法》(以下简称《公司 法》)《上市公司独立董事管理办法》（以下简称《管理办法》）《上市公司治 理准则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 及《杭州鸿泉物联网技术股份有限公司章程》(以下简称《公司章程》)的有关规 定，结合公司实际情况，制定本制度。 第二条 独立董事是指不在上市公司担任除董事外的其他职务，并与其 ...

证券代码：688288 证券简称：鸿泉技术 公告编号：2025-046 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 为进一步优化杭州鸿泉物联网技术股份有限公司（以下简称公司）治理结构， 根据《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所科 创板股票上市规则》等有关规定，并结合公司实际情况，公司于2025年12月3日 召开的第三届董事会第十二次会议以7票同意、0票反对、0票弃权、0票回避的表 决结果审议通过了《关于审议修订<公司章程>及办理工商变更登记的议案》《关 于审议制定、修订公司部分治理制度的议案》，具体情况如下： 一、《公司章程》修订情况 为进一步完善公司治理结构，提升公司规范运作水平，结合公司实际情况及 浙江省市场监督管理局的规范要求，公司拟对《杭州鸿泉物联网技术股份有限公 司章程》（以下简称《公司章程》）中的内容进行修订，具体修订情况如下： | 修订前 | 修订后 | | --- | --- | | 第七条 代表公司执行公司事务的董事为公司的 | 第七条 代表公司执行公司事务的董事为公司的 | ...

证券代码：688288 证券简称：鸿泉技术 公告编号：2025-048 杭州鸿泉物联网技术股份有限公司 关于独立董事公开征集委托投票权的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 根据中国证券监督管理委员会（以下简称中国证监会）颁布的《上市公司股 权激励管理办法》（以下简称《管理办法》）的有关规定，杭州鸿泉物联网技术 股份有限公司（以下简称公司）独立董事冯远静受其他独立董事的委托作为征集 人，就公司拟于2025年12月19日召开的2025年第二次临时股东会审议的股权激励 相关议案向公司全体股东征集投票权。 一、征集人的基本情况、对表决事项的表决意见及理由 （一）征集人的基本情况 1、本次征集投票权的征集人为公司现任独立董事冯远静，其基本情况如下： 冯远静：1976年12月出生，中国国籍，无境外永久居留权，西安交通大学博 士学位。2005年11月至2007年9月，任浙江工业大学讲师；2007年10月至2013年9 月，任浙江工业大学副教授；2010年1月至2011年1月，哈佛大学访问学者；2013 年 ...

重要内容提示： 一、 召开会议的基本情况 （一） 股东会类型和届次 2025年第二次临时股东会 证券代码：688288 证券简称：鸿泉技术 公告编号：2025-050 杭州鸿泉物联网技术股份有限公司 关于召开2025年第二次临时股东会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 召开地点：浙江省杭州市滨江区启智街 35 号鸿泉大厦公司会议室 （二） 股东会召集人：董事会 （三） 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 （四） 现场会议召开的日期、时间和地点 召开日期时间：2025 年 12 月 19 日 14 点 00 分 至2025 年 12 月 19 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 12 月 19 日 股东会召开日 ...

证券代码：688288 证券简称：鸿泉技术 公告编号：2025-045 杭州鸿泉物联网技术股份有限公司 第三届董事会第十二次会议决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 杭州鸿泉物联网技术股份有限公司（以下简称公司）第三届董事会第十二次 会议于2025年12月3日在公司会议室召开，全体董事一致同意豁免本次董事会会 议的提前通知期限。本次会议应出席董事7人，实际出席董事7人。会议由董事长 何军强先生主持。本次会议的召集、召开和表决情况符合《中华人民共和国公司 法》和《公司章程》等相关规定，会议形成的决议合法、有效。 二、董事会会议审议情况 （一）审议、通过《关于审议公司<2025 年限制性股票激励计划（草案）> 及其摘要的议案》 经审议，董事会认为公司进行2025年限制性股票激励计划将进一步建立、健 全公司长效激励机制，吸引和留住优秀人才，充分调动公司核心团队的积极性， 有效地将股东利益、公司利益和核心团队个人利益结合在一起，提升公司的市场 竞争力和可持续发展能力。董事会认为公司《202 ...

杭州鸿泉物联网技术股份有限公司 董事会薪酬与考核委员会 关于公司 2025 年限制性股票激励计划（草案）的核查意见 杭州鸿泉物联网技术股份有限公司（以下简称公司）董事会薪酬与考核委员 会依据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券 法》（以下简称《证券法》）、《上市公司股权激励管理办法》（以下简称《管理办 法》）、《上海证券交易所科创板股票上市规则》（以下简称《上市规则》）等相关 法律、法规及规范性文件和《杭州鸿泉物联网技术股份有限公司章程》（以下简 称《公司章程》）的有关规定，对公司《2025 年限制性股票激励计划（草案）》（以 下简称《激励计划（草案）》）进行了核查，发表核查意见如下： 1．公司不存在《管理办法》等法律、法规规定的禁止实施股权激励计划的 情形，包括： （1）最近一个会计年度财务会计报告被注册会计师出具否定意见或者无法 表示意见的审计报告； （2）最近一个会计年度财务报告内部控制被注册会计师出具否定意见或无 法表示意见的审计报告； （3）上市后最近 36 个月内出现过未按法律法规、公司章程、公开承诺进行 利润分配的情形； （4）法律法规规定不得实行股权激励的情形； ...

Core Viewpoint - Hongquan Technology experienced a decline of 5.04% on November 21, with a stock price of 25.99 CNY per share and a total market capitalization of 2.594 billion CNY [1] Company Overview - Hongquan Technology, established on June 11, 2009, and listed on November 6, 2019, is located in Hangzhou, Zhejiang Province. The company specializes in the research, development, production, and sales of automotive intelligent networking devices and big data cloud platforms, utilizing cutting-edge technologies such as big data, artificial intelligence, and 5G [1] - The revenue composition of the company includes: Intelligent Networking (54.66%), Intelligent Cockpit (19.26%), Controllers (13.57%), Software Platform Development (12.07%), and Others (0.44%) [1] Fund Holdings - According to data from the top ten holdings of funds, one fund under Jianxin Fund holds a significant position in Hongquan Technology. Jianxin Flexible Allocation Mixed A (000270) held 270,200 shares in the third quarter, accounting for 1.16% of the fund's net value, ranking as the ninth largest holding. The estimated floating loss today is approximately 372,900 CNY [2] - Jianxin Flexible Allocation Mixed A (000270) was established on September 3, 2013, with a latest scale of 270 million CNY. Year-to-date returns are 57.91%, ranking 443 out of 8,136 in its category; the one-year return is 53.1%, ranking 511 out of 8,056; and since inception, the return is 166.66% [2] Fund Manager Information - The fund managers of Jianxin Flexible Allocation Mixed A (000270) are Ye Letian and Guo Zhiteng. Ye Letian has a cumulative tenure of 13 years and 249 days, with a total fund asset size of 7.488 billion CNY and the best fund return during his tenure being 328.03% [3] - Guo Zhiteng has a cumulative tenure of 1 year and 351 days, managing a total fund asset size of 1.071 billion CNY, with the best fund return during his tenure being 177.81% [3]

11月20日，鸿泉技术盘中下跌2.05%，截至10:07，报27.28元/股，成交3321.66万元，换手率1.19%，总 市值27.23亿元。 截至9月30日，鸿泉技术股东户数5530.00，较上期减少7.88%；人均流通股18049股，较上期增加 7.66%。2025年1月-9月，鸿泉技术实现营业收入4.95亿元，同比增长35.85%；归母净利润4105.82万元， 同比增长237.08%。 分红方面，鸿泉技术A股上市后累计派现6500.00万元。近三年，累计派现0.00元。 责任编辑：小浪快报 今年以来鸿泉技术已经2次登上龙虎榜，最近一次登上龙虎榜为3月12日。 资料显示，杭州鸿泉物联网技术股份有限公司位于浙江省杭州市滨江区西兴街道启智街35号，成立日期 2009年6月11日，上市日期2019年11月6日，公司主营业务涉及利用大数据、人工智能及5G等前沿技术, 研发、生产和销售汽车智能网联设备及大数据云平台等产品。主营业务收入构成为：智能网联 54.66%，智能座舱19.26%，控制器13.57%，软件平台开发12.07%，其他0.44%。 鸿泉技术所属申万行业为：计算机-计算机设备-其他计算机设备。所 ...

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

Core Insights - On November 18, several companies disclosed their shareholding changes, with 康缘药业, 超达装备, and 海大集团 announcing share buybacks, while 15 companies, including 立达信 and 艾布鲁, reported share reductions [1][2]. Group 1: Share Buybacks - 康缘药业's actual controller and director, 肖伟, increased his shareholding by 20,000 shares [2]. - 超达装备 secured a stock repurchase loan commitment from China Bank for up to 450 million yuan [2]. - 海大集团 plans to repurchase shares worth no less than 1 billion yuan and up to 1.6 billion yuan [2]. Group 2: Share Reductions - 立达信's shareholder, 李春华, intends to reduce his stake by no more than 1.56% [2]. - 艾布鲁's controlling shareholder, 钟儒波, plans to reduce his stake by no more than 3% [2]. - 高德红外's actual controller, 黄立, aims to reduce his stake by no more than 3% [2]. - 嘉美包装's shareholders plan to collectively reduce their stake by no more than 1.16% [2]. - 蓄奥规划's shareholders intend to reduce their stake by no more than 1% [2]. - 君逸数码's shareholder, 成都高创投, plans to reduce his stake by no more than 1% [2]. - 联合水务's shareholder, 上海衡联, intends to reduce his stake by no more than 0.14% [2]. - 亚翔集成's second-largest shareholder has reduced 130,000 shares and is still in the reduction period [2]. - 芯朋微's controlling shareholder, 张立新, has terminated his reduction plan early [2]. - 安旭生物's shareholder, 马华祥, plans to reduce his stake by no more than 0.94% [2]. - 农心科技's shareholder, 宁波农旗, intends to reduce his stake by no more than 0.54% [2]. - 禾川科技's actual controller and others plan to reduce their stake by no more than 6% [2]. - 世龙实业's shareholder, 电化高科, plans to reduce his stake by no more than 3% [2]. - 中国化学's executive, 聂宁新, intends to reduce his stake by no more than 60,000 shares [2]. - 鸿泉技术's shareholder, 千方科技, plans to reduce his stake by no more than 3% [2].